quite likely given the further delaysone of the most frustrating companies I have bought into, delay after delay, over complicated structures and funding deals etc anyone doing due diligence on this company would think it's booby trapped
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025